Price regulation, new entry, and information shock on pharmaceutical market in Taiwan: a nationwide data-based study from 2001 to 2004
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Price regulation, new entry, and information shock on pharmaceutical market in Taiwan: a nationwide data-based study from 2001 to 2004 ; volume:10 ; number:1 ; day:25 ; month:7 ; year:2010 ; pages:1-8 ; date:12.2010
BMC health services research ; 10, Heft 1 (25.7.2010), 1-8, 12.2010
- Creator
-
Hsiao, Fei-Yuan
- Contributor
-
Tsai, Yi-Wen
Huang, Weng-Foung
SpringerLink (Online service)
- DOI
-
10.1186/1472-6963-10-218
- URN
-
urn:nbn:de:1111-2016072132523
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hsiao, Fei-Yuan
- Tsai, Yi-Wen
- Huang, Weng-Foung
- SpringerLink (Online service)
Other Objects (12)
Mergers and Barriers to Entry in Pharmaceutical Markets
Mergers and Barriers to Entry in Pharmaceutical Markets
Nationwide surveillance algorithms for tuberculosis among immigrant workers from highly endemic countries following pre-entry screening in Taiwan
Do cost-sharing and entry deregulation curb pharmaceutical Innovation?
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry
Does increased price competition reduce entry of new pharmaceutical products?
Common Ownership and Market Entry : Evidence from the Pharmaceutical Industry
Nationwide epidemiological study of severe gallstone disease in Taiwan
Size and dynamics of order-of-entry effects in pharmaceutical markets
Size and Dynamics of Order-of-Entry Effects in Pharmaceutical Markets
Effectiveness of pharmaceutical strategies for pandemic H1N1 2009 influenza in TAIWAN
Data-based therapy recommender systems
Mergers and Barriers to Entry in Pharmaceutical Markets
Mergers and Barriers to Entry in Pharmaceutical Markets
Nationwide surveillance algorithms for tuberculosis among immigrant workers from highly endemic countries following pre-entry screening in Taiwan
Do cost-sharing and entry deregulation curb pharmaceutical Innovation?
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry
Does increased price competition reduce entry of new pharmaceutical products?
Common Ownership and Market Entry : Evidence from the Pharmaceutical Industry
Nationwide epidemiological study of severe gallstone disease in Taiwan
Size and dynamics of order-of-entry effects in pharmaceutical markets
Size and Dynamics of Order-of-Entry Effects in Pharmaceutical Markets
Effectiveness of pharmaceutical strategies for pandemic H1N1 2009 influenza in TAIWAN
Data-based therapy recommender systems
Mergers and Barriers to Entry in Pharmaceutical Markets
Mergers and Barriers to Entry in Pharmaceutical Markets
Nationwide surveillance algorithms for tuberculosis among immigrant workers from highly endemic countries following pre-entry screening in Taiwan
Do cost-sharing and entry deregulation curb pharmaceutical Innovation?
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry
Does increased price competition reduce entry of new pharmaceutical products?
Common Ownership and Market Entry : Evidence from the Pharmaceutical Industry
Nationwide epidemiological study of severe gallstone disease in Taiwan
Size and dynamics of order-of-entry effects in pharmaceutical markets
Size and Dynamics of Order-of-Entry Effects in Pharmaceutical Markets
Effectiveness of pharmaceutical strategies for pandemic H1N1 2009 influenza in TAIWAN